Long-term study of mitochondrial replacement therapy in monkeys finds no adverse health effects

Findings add safety, efficacy support for gene therapy developed at OHSU

By Erik Robinson December 08, 2020 Portland, Oregon

Downloads

New long-term research in rhesus macaques led by Shoukhrat Mitalipov, Ph.D., bolsters the case for moving mitochondrial replacement therapy to human clinical trials in the United States. (OHSU/Kristyna Wentz-Graff)

OHSU/Kristyna Wentz-Graff

Paula Amato, M.D. (OHSU)

Shoukhrat Mitalipov, Ph.D.

Shoukhrat Mitalipov, Ph.D., director of the OHSU Center for Embryonic Cell and Gene Therapy. (OHSU/Jeffrey Ball)